Description
Apalutamide is an androgen receptor inhibitor that blocks the effect of androgens on the tumor. Specifically, apalutamide binds to the ligand-binding domain of the androgen receptor, blocks androgen-receptor nuclear translocation, inhibits DNA binding, and obstructs androgen receptor–mediated transcription.
Indication
Apalunix (apalutamide) is an androgen receptor inhibitor indicated for the treatment of patients with:
- Metastatic castration-sensitive prostate cancer (mCSPC)
- Non-metastatic castration-resistant prostate cancer (nmCRPC)
Side Effects of Apalutamide Tablet
Hot flashes, tiredness, joint pain, nausea, decreased appetite, weight loss. If any of these effects last or get worse, tell your doctor or pharmacist promptly.
